These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33655395)

  • 1. Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy.
    Narayanaswamy R; Torchilin VP
    Pharm Res; 2021 Mar; 38(3):429-450. PubMed ID: 33655395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-conjugated pH-sensitive liposomes for HER-2 positive breast cancer: development, characterization,
    Raikwar S; Yadav V; Jain S; Jain SK
    J Liposome Res; 2024 Jun; 34(2):239-263. PubMed ID: 37594466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel.
    Muntimadugu E; Kumar R; Saladi S; Rafeeqi TA; Khan W
    Colloids Surf B Biointerfaces; 2016 Jul; 143():532-546. PubMed ID: 27045981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
    Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C
    Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effect of paclitaxel-loaded PEGylated immunoliposomes against human breast cancer cells.
    Yang T; Choi MK; Cui FD; Lee SJ; Chung SJ; Shim CK; Kim DD
    Pharm Res; 2007 Dec; 24(12):2402-11. PubMed ID: 17828616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy.
    Eloy JO; Petrilli R; Topan JF; Antonio HMR; Barcellos JPA; Chesca DL; Serafini LN; Tiezzi DG; Lee RJ; Marchetti JM
    Colloids Surf B Biointerfaces; 2016 May; 141():74-82. PubMed ID: 26836480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-GD2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells.
    Gholizadeh S; Dolman EM; Wieriks R; Sparidans RW; Hennink WE; Kok RJ
    Pharm Res; 2018 Mar; 35(4):85. PubMed ID: 29516187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.
    Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
    Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity.
    Koren E; Apte A; Jani A; Torchilin VP
    J Control Release; 2012 Jun; 160(2):264-73. PubMed ID: 22182771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated-Paclitaxel and Dihydroartemisinin Nanoparticles for Simultaneously Delivering Paclitaxel and Dihydroartemisinin to Colorectal Cancer.
    Phung CD; Le TG; Nguyen VH; Vu TT; Nguyen HQ; Kim JO; Yong CS; Nguyen CN
    Pharm Res; 2020 Jun; 37(7):129. PubMed ID: 32548664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin-loaded Immunoliposomes Functionalized with Trastuzumab: A Strategy to Enhance Cytotoxicity to HER2-positive Breast Cancer Cells.
    Eloy JO; Petrilli R; Brueggemeier RW; Marchetti JM; Lee RJ
    Anticancer Agents Med Chem; 2017; 17(1):48-56. PubMed ID: 27225450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice.
    Gupta B; Torchilin VP
    Cancer Immunol Immunother; 2007 Aug; 56(8):1215-23. PubMed ID: 17219149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models.
    Apte A; Koren E; Koshkaryev A; Torchilin VP
    Cancer Biol Ther; 2014 Jan; 15(1):69-80. PubMed ID: 24145298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy.
    Eloy JO; Petrilli R; Chesca DL; Saggioro FP; Lee RJ; Marchetti JM
    Eur J Pharm Biopharm; 2017 Jun; 115():159-167. PubMed ID: 28257810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines.
    Elbayoumi TA; Torchilin VP
    Eur J Pharm Sci; 2007 Nov; 32(3):159-68. PubMed ID: 17707615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of drug-conjugated SWCNT nanocarriers for efficient therapy of cancer stem cells in a breast cancer animal model.
    Al Faraj A; Shaik AS; Ratemi E; Halwani R
    J Control Release; 2016 Mar; 225():240-51. PubMed ID: 26827662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E-based redox-sensitive salinomycin prodrug-nanosystem with paclitaxel loaded for cancer targeted and combined chemotherapy.
    Liang DS; Liu J; Peng TX; Peng H; Guo F; Zhong HJ
    Colloids Surf B Biointerfaces; 2018 Dec; 172():506-516. PubMed ID: 30212688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of epirubicin and paclitaxel using an estrone-targeted PEGylated liposomal nanoparticle for breast cancer.
    Tang H; Chen J; Wang L; Li Q; Yang Y; Lv Z; Bao H; Li Y; Luan X; Li Y; Ren Z; Zhou X; Cong D; Liu Z; Jia J; Chen H; Zhao W; Meng Q; Sun F; Pei J
    Int J Pharm; 2020 Jan; 573():118806. PubMed ID: 31678519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes.
    Niu R; Zhao P; Wang H; Yu M; Cao S; Zhang F; Chang J
    J Drug Target; 2011 Jun; 19(5):373-81. PubMed ID: 20677917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles.
    Gao J; Liu J; Xie F; Lu Y; Yin C; Shen X
    Int J Nanomedicine; 2019; 14():9199-9216. PubMed ID: 32063706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.